New Study Finds Cannabinoids May Offer A Safer Pain Relief Option Without Addiction Risks
January 31st 2025Yale researchers investigated in a recent study how cannabinoids can be used as an alternative chronic pain treatment without addiction risks and found that they can help lower pain signals in Nav1.8.
DEA Cannabis Rescheduling Hearing Postponement Insights: An Interview with Adam Goers
January 21st 2025Adam Goers, SVP of Corporate Affairs for The Cannabist Company and the co-chair of the Coalition for Cannabis Scheduling Reform (CCSR), discusses the recent cancellation of the DEA cannabis rescheduling hearing, how this delay could be strategic and necessary to ensure a legitimate outcome that may benefit the interested parties seeking the rescheduling.